Medical Communications

Showing 15 posts of 6053 posts found.

ZOLL remedē System receives FDA approval for sleep apnoea treatment

May 25, 2023 Medical Communications Ear Nose & throat, FDA, ZOLL, sleep apnoea

ZOLL Medical Corporation has announced that it has received approval from the US Food and Drug Administration (FDA) for its …
national-cancer-institute-kmvohcb-w5g-unsplash_1

AstraZeneca shares oncology data at ASCO 2023

May 25, 2023 Medical Communications ASCO, AstraZeneca, Cancer, Oncology, oncology

AstraZeneca plans to share data from its oncology pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting on …

Artivion receives FDA PMA approval of PerClot; transfers designation to Baxter

May 24, 2023 Medical Communications Artivion, Baxter International, Cardiology, FDA, PMA, PerClot

US cardiac and vascular surgery company Artivion has announced that the US Food and Drug Administration (FDA) has granted a …

FDA approves Innoviva’s Xacduro for intravenous use

May 24, 2023 Medical Communications FDA, Infections and infestations, Innoviva, pneumonia

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, has announced that the US Food and Drug Administration (FDA) has approved Xacduro …

Rocket Pharmaceuticals granted FDA RMAT designation for gene therapy

May 24, 2023 Medical Communications FDA, Haematology, RMAT, Rocket Pharmaceuticals, gene therapy

Rocket Pharmaceuticals, a US-based biotechnology company, has announced that it has received US Food and Drug Administration (FDA) Regenerative Medicine …

More infections from contaminated eyedrops increase death toll

May 23, 2023 Medical Communications FDA, Opthalmology, eyedrops, infections

The US Centers for Disease Control and Prevention (CDC) have released updated data regarding contaminated eyedrops. As of May 2023, …

Grünenthal receives FDA Breakthrough Therapy Designation for knee osteoarthritis drug

May 23, 2023 Medical Communications Breakthrough Therapy Designation, FDA, Grunenthal, Musculo-skeletal disorder, osteoarthritis

German pharmaceutical company Grünenthal has announced that the US Food and Drug Administration (FDA) has awarded it Breakthrough Therapy Designation …

FDA approves prescription nasal spray for opioid overdose treatment

May 23, 2023 Medical Communications FDA, Nasal Spray, Opvee, Poisoning and drug dependency, opioids, overdose

The US Food and Drug Administration (FDA) has announced that it has approved Opvee, the first nalmefene hydrochloride nasal spray …

FDA approves new insulin pump and algorithm software for enhanced automated insulin delivery

May 22, 2023 Medical Communications Devices, FDA, diabetes, insulin

The US Food and Drug Administration (FDA) has announced that it has cleared the Beta Bionics iLet ACE Pump and …
national-cancer-institute-l8twzt4ccvq-unsplash_1

Swing Therapeutics receives FDA authorisation for digital therapeutic for fibromyalgia

May 22, 2023 Medical Communications CBT, Devices, FDA, Swing Therapeutics, fibromyalgia

Swing Therapeutics has announced that it has received De Novo marketing authorisation from the US Food and Drug Administration for …
brano-mm1vipqd0oa-unsplash

Krystal Biotech secures FDA approval for redosable topical gene therapy

May 22, 2023 Medical Communications FDA, Krystal Biotech, Paediatrics, dystrophic epidermolysis bullosa, gene therapy

US-based biotech company Krystal Biotech has announced that the US Food and Drug Administration (FDA) has approved its topical gene …

Schott Pharma announces pre-filled polymer syringes for deep-cold medication

May 19, 2023 Medical Communications Devices, Schott Pharma, deep cold medication, syringe

Germany-based drug delivery solutions company Schott Pharma has announced its pre-fillable syringes (PFS) for drugs requiring deep-cold, such as those …
milad-fakurian-58z17lnvs4u-unsplash_2

NHS given guidance on offering genetic testing to stroke patients

May 19, 2023 Medical Communications NHS, Neurology, blood clot, genetic testing, stroke

The NHS has been given draft guidance on offering gene tests to patients who have had a stroke caused by …

NICE recommends Kapruvia for treatment of moderate-to-severe CKD-associated pruritus

May 18, 2023 Medical Communications Kapruvia, NICE, Nephrology, chronic kidney disease, pruritus

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics have announced that the National Institute for Health and Care …

US appeals court hears arguments in abortion pill case

May 18, 2023 Medical Communications Obstetrics & Gynaecology, abortion, medication abortion, mifepristone, reproduction

The ongoing court battle surrounding the contested approval of mifepristone, one of the drugs used in medication abortions, has now …

Latest content